Franklin Lakes, N.J.-based Becton, Dickinson and Co. will acquire C. R. Bard — a Murray Hill, N.J.-based medical technology manufacturer, for $24 million in cash and stock.
Through the acquisition, BD — a medical equipment supplier — will expand its portfolio to include vascular, urology, oncology and surgical specialty products.
Both companies' boards unanimously approved the agreement, and the deal is expected to close in fall 2017.
More articles on supply chain:
FDA finalizes decision to keep impounded execution drugs from Texas justice system
Sanofi epilepsy drug linked to birth deformities
Marathon 2nd drugmaker to resign from PhRMA this month